Tradestie Institutional Equity Comparison Engine
FLZH vs BIAF โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BIAF Overall Edge
BIAF Captures Institutional Edge (2โ0 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to bioAffinity Technologies, Inc. Common Stock (BIAF) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, FLZH trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BIAF at N/M Forward P/E and -246.1% operating margin (-26.0% YoY). In options structure, FLZH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BIAF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
FLZH N/M vs BIAF N/M Fwd P/E
Growth & Margin Winner
BIAF
Op Margin N/A vs -246.1% ยท YoY N/A vs -26.0%
Momentum & Technical Winner
BIAF
1Y -97.5% vs +12.2% ยท 52W Pos 0% vs 7%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
FLZH
US Equity
FLZH
Institutional Equity
$0.10
-56.54% 1D
Market Cap
N/A
1M Return
-92.93%
1Y Return
-97.5%
Forward P/E
N/M
Unified AI Score
48.8 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
BIAF
NASDAQ
bioAffinity Technologies, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.65
-10.81% 1D
Market Cap
$3.3M
1M Return
-47.95%
1Y Return
+12.24%
Forward P/E
N/M
Unified AI Score
48.0 / 100
HOLD
Tech 38.0
Fund 51.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FLZH -97.5%
BIAF +12.24%
Spread: +546.82 pp (BIAF Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
FLZH TTM Op. Margin: N/A
BIAF TTM Op. Margin: -246.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FLZH vs BIAF. Trailing 12-month operating profitability (FLZH N/A vs BIAF -246.1%) and valuation multiples (FLZH N/M vs BIAF N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FLZH | BIAF | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $3.3M | Larger Scale | BIAF |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | -26.0% | Higher Growth | BIAF |
| Operating Margin (TTM) Profitability | N/A | -246.1% | Higher Margin | BIAF |
| Net Profit Margin Profitability | N/A | -278.9% | Higher Margin | BIAF |
| Return on Equity (ROE) Capital Efficiency | N/A | -240.5% | Higher ROE | BIAF |
| 52-Week Range Position Momentum | 0% ($0โ$4) | 7% ($0โ$20) | Stronger Trend | BIAF |
| Beta / 30D Volatility Risk Regime | 3.90ฮฒ ยท 329% Vol | -0.62ฮฒ ยท 120% Vol | Lower Realized Risk | BIAF |
| Unified Institutional Score Composite Signal | 48.8 / 100 (HOLD) | 48.0 / 100 (HOLD) | Higher Composite | FLZH |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FLZH vs BIAF Buy Guide
FLZH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BIAF
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FLZH nor BIAF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.